NASDAQ · RACA
Therapeutics Acquisition Corp.
Financial Services · Shell Companies
$10.27
Up+$0.24 (+2.44%)
Updated Sep 11, 2026, 6:00 AM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 31.33K
- Avg. volume
- 137.58K
Price performance
RACA price history
1M range · 0 trading sessions · Daily adjusted prices
RACA does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest RACA news
The latest Smart Investors Daily articles mentioning RACA.
Stock researchCompany · Overview
RACA research
Overview
Company profile and research snapshot.
Company profile
Therapeutics Acquisition Corp., doing business as Research Alliance Corp. I, intends to effect a merger, capital stock exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare industry in the United States. The company was founded in 2020 and is based in Boston, Massachusetts.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
